Market Overview:
The global pseudotumor cerebri market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing incidence of obesity, rising prevalence of chronic diseases, and growing awareness about pseudotumor cerebri. Based on type, the global pseudotumor cerebri market is segmented into fundoscopy, neuroimaging, and lumbar puncture. The fundoscopy segment is expected to account for the largest share of the global pseudotumor cerebri market in 2018. This can be attributed to the increasing use of funduscopy for early diagnosis and treatment of pseudotumor cerebri. Based on application, the global Pseudotumor Cerebri Market is segmented into spinal fluid shunt placement surgery (SFS), optic nerve sheath fenestration (ONSF), venous sinus stenting (VSS), and medication therapy/management.
Product Definition:
Pseudotumor cerebri is a neurological disorder that is marked by an increase in the pressure of the fluid that surrounds the brain. This condition can cause a wide range of symptoms, including headaches, vision problems, and dizziness. Pseudotumor cerebri is most often seen in women who are obese or who take certain medications, such as birth control pills or high blood pressure medications. The importance of pseudotumor cerebri lies in its ability to cause serious vision problems if left untreated.
Fundoscopy:
Fundoscopy is a diagnostic procedure for visualizing the interior of the brain. It is performed by using an optical device called a fundus camera. The normal process of looking at the retina and then processing information to form images & videos what we see on our retinas are known as fundoscopy and vitreoscopy respectively.
Neuroimaging:
Neuroimaging is a procedure that involves the use of various imaging techniques to observe and analyze the functioning of the brain. The procedures include magnetic resonance imaging (MRI), computed tomography (CT) scanning, single-photon emission computerized axial tomography (SPECT), functional Magnetic Resonance Imaging (fMRI) and Transcranial Electrical Motor Evoked Potentials(TCeMEP).
Application Insights:
Based on application, the global market is segmented into spinal fluid shunt, optic nerve sheath fenestration, venous sinus stenting, medication and others. The spinal fluid shunt held the largest share in 2017 owing to its high usage rate and preference among healthcare professionals for CSF management. However, with growing awareness regarding adverse effects of this procedure such as hydrocephalus or increased ICP there has been a decline in its usage rate over the past few years. Optic nerve sheath fenestration is expected to be one of the fastest-growing segments during forecast period due to increasing prevalence of eye disorders along with technological advancements in surgical procedures that are used for their treatment such as optic neurosurgery or transconjunctival surgery.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing fundoscopic procedures, technological advancements, and high prevalence of glaucoma among the U.S.-based population. The Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to an increase in geriatric population and number of surgeries performed for various reasons such as spinal fluid shunt procedures or venous sinus stenting/fistulotomy (for drainage purposes). Moreover, rising awareness about brain tumor diagnosis using noninvasive techniques is anticipated to drive regional growth over the forecast period.
Major players operating in this industry are Carl Zeiss Meditec Group; Nikon Corporation; Ophtecs Corporation; Optomed Oy (Optic Systems); Optitech Eyecare Ltd.; PerkinElmer Inc.; SurgVision International Pty Ltd.; US WorldMate Inc.; Visionsense Pty Ltd.
Growth Factors:
- Increasing incidence of Pseudotumor Cerebri
- Rising awareness about Pseudotumor Cerebri and its symptoms
- Growing number of research and development activities for the treatment of Pseudotumor Cerebri
- Technological advancements in the diagnosis and treatment of Pseudotumor Cerebri
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Pseudotumor Cerebri Market Research Report
By Type
Fundoscopy, Neuroimaging, Lumbar Puncture
By Application
Spinal Fluid Shunt, Optic Nerve Sheath Fenestration, Venous Sinus Stenting, Medication
By Companies
Avkare, Inc., B. Braun Melsungen AG, Beckersmith Medical, Inc., Elekta AB, Heritage Pharmaceuticals Inc., Ingenus Pharmaceuticals, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Lannett Company, Inc., Magstim, Medtronic, MercuryPharma, Nostrum Laboratories Inc., Novast Holdings Ltd., Phoenix Biomedical Corp., Sanofi, SGPharma Pvt. Ltd., Sophysa, Taro Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., West-Ward Pharmaceutical, Zydus Pharmaceuticals, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
172
Number of Tables & Figures
121
Customization Available
Yes, the report can be customized as per your need.
Global Pseudotumor Cerebri Market Report Segments:
The global Pseudotumor Cerebri market is segmented on the basis of:
Types
Fundoscopy, Neuroimaging, Lumbar Puncture
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Spinal Fluid Shunt, Optic Nerve Sheath Fenestration, Venous Sinus Stenting, Medication
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Avkare, Inc.
- B. Braun Melsungen AG
- Beckersmith Medical, Inc.
- Elekta AB
- Heritage Pharmaceuticals Inc.
- Ingenus Pharmaceuticals
- Integra LifeSciences Corporation
- Johnson & Johnson Services, Inc.
- Lannett Company, Inc.
- Magstim
- Medtronic
- MercuryPharma
- Nostrum Laboratories Inc.
- Novast Holdings Ltd.
- Phoenix Biomedical Corp.
- Sanofi, SGPharma Pvt. Ltd.
- Sophysa
- Taro Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- West-Ward Pharmaceutical
- Zydus Pharmaceuticals, Inc.
Highlights of The Pseudotumor Cerebri Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fundoscopy
- Neuroimaging
- Lumbar Puncture
- By Application:
- Spinal Fluid Shunt
- Optic Nerve Sheath Fenestration
- Venous Sinus Stenting
- Medication
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pseudotumor Cerebri Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pseudotumor cerebri is a condition in which there is an increase in the size of the brain. This can be caused by a number of things, including head trauma, infection, and tumors.
Some of the key players operating in the pseudotumor cerebri market are Avkare, Inc., B. Braun Melsungen AG, Beckersmith Medical, Inc., Elekta AB, Heritage Pharmaceuticals Inc., Ingenus Pharmaceuticals, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Lannett Company, Inc., Magstim, Medtronic, MercuryPharma, Nostrum Laboratories Inc., Novast Holdings Ltd., Phoenix Biomedical Corp., Sanofi, SGPharma Pvt. Ltd., Sophysa, Taro Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., West-Ward Pharmaceutical, Zydus Pharmaceuticals, Inc..
The pseudotumor cerebri market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pseudotumor Cerebri Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Pseudotumor Cerebri Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Pseudotumor Cerebri Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Pseudotumor Cerebri Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Pseudotumor Cerebri Market Size & Forecast, 2018-2028 4.5.1 Pseudotumor Cerebri Market Size and Y-o-Y Growth 4.5.2 Pseudotumor Cerebri Market Absolute $ Opportunity
Chapter 5 Global Pseudotumor Cerebri Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pseudotumor Cerebri Market Size Forecast by Type
5.2.1 Fundoscopy
5.2.2 Neuroimaging
5.2.3 Lumbar Puncture
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pseudotumor Cerebri Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pseudotumor Cerebri Market Size Forecast by Applications
6.2.1 Spinal Fluid Shunt
6.2.2 Optic Nerve Sheath Fenestration
6.2.3 Venous Sinus Stenting
6.2.4 Medication
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pseudotumor Cerebri Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pseudotumor Cerebri Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pseudotumor Cerebri Analysis and Forecast
9.1 Introduction
9.2 North America Pseudotumor Cerebri Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pseudotumor Cerebri Market Size Forecast by Type
9.6.1 Fundoscopy
9.6.2 Neuroimaging
9.6.3 Lumbar Puncture
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pseudotumor Cerebri Market Size Forecast by Applications
9.10.1 Spinal Fluid Shunt
9.10.2 Optic Nerve Sheath Fenestration
9.10.3 Venous Sinus Stenting
9.10.4 Medication
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pseudotumor Cerebri Analysis and Forecast
10.1 Introduction
10.2 Europe Pseudotumor Cerebri Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pseudotumor Cerebri Market Size Forecast by Type
10.6.1 Fundoscopy
10.6.2 Neuroimaging
10.6.3 Lumbar Puncture
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pseudotumor Cerebri Market Size Forecast by Applications
10.10.1 Spinal Fluid Shunt
10.10.2 Optic Nerve Sheath Fenestration
10.10.3 Venous Sinus Stenting
10.10.4 Medication
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pseudotumor Cerebri Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pseudotumor Cerebri Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pseudotumor Cerebri Market Size Forecast by Type
11.6.1 Fundoscopy
11.6.2 Neuroimaging
11.6.3 Lumbar Puncture
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pseudotumor Cerebri Market Size Forecast by Applications
11.10.1 Spinal Fluid Shunt
11.10.2 Optic Nerve Sheath Fenestration
11.10.3 Venous Sinus Stenting
11.10.4 Medication
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pseudotumor Cerebri Analysis and Forecast
12.1 Introduction
12.2 Latin America Pseudotumor Cerebri Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pseudotumor Cerebri Market Size Forecast by Type
12.6.1 Fundoscopy
12.6.2 Neuroimaging
12.6.3 Lumbar Puncture
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pseudotumor Cerebri Market Size Forecast by Applications
12.10.1 Spinal Fluid Shunt
12.10.2 Optic Nerve Sheath Fenestration
12.10.3 Venous Sinus Stenting
12.10.4 Medication
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pseudotumor Cerebri Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pseudotumor Cerebri Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pseudotumor Cerebri Market Size Forecast by Type
13.6.1 Fundoscopy
13.6.2 Neuroimaging
13.6.3 Lumbar Puncture
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pseudotumor Cerebri Market Size Forecast by Applications
13.10.1 Spinal Fluid Shunt
13.10.2 Optic Nerve Sheath Fenestration
13.10.3 Venous Sinus Stenting
13.10.4 Medication
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pseudotumor Cerebri Market: Competitive Dashboard
14.2 Global Pseudotumor Cerebri Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Avkare, Inc.
14.3.2 B. Braun Melsungen AG
14.3.3 Beckersmith Medical, Inc.
14.3.4 Elekta AB
14.3.5 Heritage Pharmaceuticals Inc.
14.3.6 Ingenus Pharmaceuticals
14.3.7 Integra LifeSciences Corporation
14.3.8 Johnson & Johnson Services, Inc.
14.3.9 Lannett Company, Inc.
14.3.10 Magstim
14.3.11 Medtronic
14.3.12 MercuryPharma
14.3.13 Nostrum Laboratories Inc.
14.3.14 Novast Holdings Ltd.
14.3.15 Phoenix Biomedical Corp.
14.3.16 Sanofi, SGPharma Pvt. Ltd.
14.3.17 Sophysa
14.3.18 Taro Pharmaceutical Industries Ltd.
14.3.19 Teva Pharmaceutical Industries Ltd.
14.3.20 West-Ward Pharmaceutical
14.3.21 Zydus Pharmaceuticals, Inc.